Peter Shaw

11PUBLICATIONS
115CO-AUTHORS
Infant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesHaematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 04, 2026
Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study.

Khalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup

|Jan 13, 2026
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT).

Selim Corbacioglu, Rajinder Bajwa, Ali Bülent Antmen

|Jul 29, 2024
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.

Tim Bognàr, Moises Garcia-Rosa, Arief Lalmohamed

|May 23, 2024
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

Matt S Zinter, Christopher C Dvorak, Madeline Y Mayday

|May 20, 2024
Outcomes from hematopoietic stem cell transplantation following treosulfan-based conditioning: A clinical and pharmacokinetic analysis.

Sebastian P A Rosser, Alice Brewer, Melissa Gabriel

|Oct 24, 2022
Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

C Schuetz, J Gerke, M Ege

Pageof 2

Frequent Collaborators

3 joint publications

Jaap-Jan Boelens

3 joint publications

Tayfun Güngör

2 joint publications

Christa E Nath

2 joint publications

Maja Krajinovic